Wednesday, August 8, 2018

SinglePoint (OTCQB: $SING) Provides Update Highlighting Increased Revenue, Acquisitions, and SEC Filing


SinglePoint (OTCQB: $SING) Provides Update Highlighting Increased Revenue, Acquisitions, and SEC Filing



SEATTLE - August 8, 2018 (Investorideas.com Newswire) SinglePoint Inc. (OTC:SING) provides overall company update including revenue, Form 10, acquisitions. SinglePoint over the past year has been able to successfully integrate its acquisitions and reported revenues of over $188,000 for the first quarter of 2018, which represents a significant increase as compared to the first quarter of 2017. This revenue increase has been generated by successful acquisitions continuing to grow and operate, including DIGS and JAG.

Acquisitions have been a key factor in starting to build a solid financial base and we intend to continue to grow the company. We hope that our growth will continue both organically and with larger investments and or acquisitions which can further solidify our financial position.


"We built a solid base throughout 2017 and have been building upon that in 2018 which has led to SinglePoint starting to generate a major increase in revenue compared to previous years. We are looking to acquire companies that are cash flow positive. This will give SinglePoint the ability to operate and continue taking risks in hyper growth opportunities", states Greg Lambrecht CEO.

We believe that our recently filed Form 10-12G with the SEC will provide more transparency and credibility which will open doors to future growth. SinglePoint is hopeful that with these new opportunities the company can continue to build shareholder value and long-term appreciation, through marketing and sales of current suite of services as well as acquisitions.

About SinglePoint, Inc.
SinglePoint, Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed, the company is providing products and services to the cannabis industry.


For more information visit: 
www.SinglePoint.com 

Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Corporate Communications Contact:
SinglePoint Inc.
855-711-2009
info@SinglePoint.com
Singlepoint.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office

Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com
SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com
Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. SinglePoint, Inc. (OTC: SING) is a paid PR news and social media client on Investorideas.com for bitcoin and cannabis – more details http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp



Tuesday, August 7, 2018

Investorideas.com - Medical #Cannabis - What Does it Mean for Texas?

Investorideas.com - Medical #Cannabis - What Does it Mean for Texas?

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CSE New #Cannabis Listing: CordovaCann Corp. (CDVA); @CSE_News

Investorideas.com - CSE New #Cannabis Listing: CordovaCann Corp. (CDVA); @CSE_News

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $ACB.TO, TSX: $WEED.TO, NYSE: $CGC, CSE: $CRZ.C, CSE: $PVOT.C, TSXV: $GENE.V


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $ACB.TO, TSX: $WEED.TO, NYSE: $CGC, CSE: $CRZ.C, CSE: $PVOT.C, TSXV: $GENE.V

August 7th Potcast sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH



Delta, Kelowna, BC –August 7, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP.  Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com

Today’s podcast features news announcements from Liberty Health Sciences Inc. trading on the CSE as LHS, Aurora Cannabis Inc. trading on the TSX as ACB and the OTCQB as ACBFF, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as CGC, CannaRoyalty Corp. trading on the CSE as CRZ, Pivot Pharmaceuticals Inc. trading on the CSE as PVOT and the OTCQB as PVOTF and INVICTUS MD STRATEGIES CORP. trading on the TSX-Venture as GENE.  

Liberty Health Sciences Inc., a provider of high quality pharmaceutical grade cannabis, announced today that it has doubled its cultivation space in Florida with production commencing at its Liberty Health Sciences 360 Innovation Campus in Gainesville in response to the growing demand by Florida patients. The Company received permission to commence production at the 360 Campus while a retrofit of the facilities is being completed. The Company's Chestnut Hill facility continues to operate at full capacity.

The Company also announced that it has five more leases in place for Cannabis Education Centers including: Boca Raton, Gainesville, Winterhaven, Palm Harbor and Sarasota.

In accordance with the Company's rapidly expanding presence in Florida, production of Liberty's newest and highly anticipated offering to consumers, Mary's Medicinals, has commenced production. The entire award-winning line of innovative Mary's products will soon be available in all of Liberty's Cannabis Education Centers (CEC). Products will include: transdermal patches, transdermal gel pens, topicals, capsules, tinctures and vape pens.

Aurora Cannabis Inc. announced today that it has entered into a letter of intent whereby Aurora intends to acquire the cannabis business of HotHouse Consulting Inc., a provider of advanced greenhouse consulting services.
Founded by industry veteran Laust Dam in 2004, HotHouse specializes in hybrid greenhouse growing techniques. Since its founding, HotHouse has consulted on a variety of agricultural crops but has focused in recent years on the specialized requirements of large scale cannabis production. With more than 70 years of combined experience, HotHouse's team of consultants currently provide services for approximately 50 customers globally. Upon closing of the acquisition, Laust Dam will join Aurora Larssen Projects ("ALPS") as VP of Horticultural Development.

Canopy Growth Corporation announced that it has completed the previously announced acquisition of Canopy Health Innovations Inc. ("CHI"), including the subsidiary operations of Canopy Animal Health Inc. ("CAH"). The Company believes its strategy of integrating and aligning CHI's clinical platform with the international work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and formulations and ultimately improve patient access to medical cannabis globally.

CHI has built a diversified business focused on unlocking the therapeutic and commercial potential of cannabis for both humans and animals. Incorporating CHI into this ecosystem as a wholly-owned subsidiary will increase efficiencies and unlock the full potential of CHI's significant IP portfolio including 39 patent applications filed with the United States Patent Trade Office.

CannaRoyalty Corp., a leading North American cannabis products and brands company, today announced that it plans to release its financial results for the second quarter ended June 30, 2018 on Thursday, August 23, 2018 at 6:30 a.m. ET.
The Company will host a conference call on Thursday, August 23, 2018 at 8:30 a.m. ET to discuss financial results and provide investors with key business highlights. The call will be chaired by Marc Lustig, Chairman and Chief Executive Officer, François Perrault, Chief Financial Officer and Afzal Hasan, President and General Counsel.

Pivot Pharmaceuticals Inc. announced that it has signed a Definitive Agreement with Israeli-based SoluBest Ltd. to acquire the worldwide rights for the use, development and commercialization of its patented Solumer™ Oral Drug Delivery Technology ("Solumer™") for the improved bioavailability, delivery and commercialization of Cannabidiol (CBD), Tetrahydrocannabinol (THC) and other biocannabis-based products.

A patented and versatile technology, Solumer™ was developed by SoluBest Ltd. to maximize the solubility, bioavailability and physical stability of drug substances utilizing submicron particle engineering. SoluBest then achieves clear powder formulations through a spray drying process. Submicron technology has been proven in pre-clinical trials to significantly enhance bioavailability, and therefore drug performance. Dissolution profiles in intestinal media demonstrate a high dissolution rate and saturation solubility resulting in improved drug absorption, at a rate 10-15 times greater than control.

In 2016, cannabinoid edibles accounted for approximately 16% of U.S. sales of cannabis products.1 Furthermore, Cannabiz Consumer Group states that cannabis-infused beverages could represent a $15 billion market opportunity upon legalization.

INVICTUS MD STRATEGIES CORP. announced that its wholly owned subsidiary, Acreage Pharms Ltd., has received an amended license from Health Canada, under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), to include the production of bottled cannabis oil and cannabis resin, effective August 3, 2018.
Acreage Pharms' state-of-the-art closed-loop CO2 extraction process produces the highest-quality cannabis oils in the world. The system performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure carbon dioxide to extract essential oils from botanicals, using specific temperatures and pressures to withdraw different components from plants. Through this extraction process, CBD and THC levels can be adjusted to ensure a diverse selection for consumers.  

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher,  iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact Investorideas.com

This podcast is sponsored by Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com



Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


Friday, August 3, 2018

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $TBP.V, CSE: $GLH.C, OTCQB: $GSRX, TSXV: $ABCN.V, OTC: $ADYNF



Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $TBP.V, CSE: $GLH.C, OTCQB: $GSRX, TSXV: $ABCN.V, OTC: $ADYNF

August 3rd Potcast sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH



Delta, Kelowna, BC –August 3, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.



Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP.  Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com

Today’s podcast features news from Tetra Bio-Pharma Inc. trading on the TSX-VENTURE as TBP and the OTCQB as TBPMF, Golden Leaf Holdings Ltd. trading on the CSE as GLH and the OTCQB as GLDFF, GSRX Industries Inc. trading on the OTCQB as GSRX, ABcann Global Corporation trading on the TSX-Venture as ABCN and OTCQB as ABCCF and ALGAE DYNAMICS CORP trading on the OTC as ADYNF.

Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development, today announced that the company has provided an extension to North Bud Farms Inc.  Tetra and North Bud Farms Inc. are working diligently to finalize the transaction and to this end Tetra Bio-Pharma has agreed to provide an extension to North Bud Farms Inc. with regards to the final receipt of North Bud’s prospectus’.  As one of the closing conditions to the sale these documents must now be submitted by August 31, 2018.  Upon final receipt of North Bud’s prospectus and meeting the requirements requested by the Ontario Securities Commission, Tetra will announce the record date and begin the process with the distribution of the dividend which must be finalized before listing the shares of North Bud Farms Inc. 

Golden Leaf Holdings Ltd., a cannabis company with cultivation, production and retail operations built around recognized brands, today announced its upcoming attendance at a number of major cannabis industry and investor events.
From August 8 to 9, Golden Leaf CEO William Simpson will present at the Canaccord Genuity’s 38th Annual Growth Conference taking place in Boston, Massachusetts. The Canaccord conference is a premier investment forum for innovative small and mid-cap growth companies from the U.S., Canada, and the U.K.

Later in the month, management will attend MJBIZCon Int’l in Toronto, Ontario from August 14 to 16 as well as CEO William Simpson will also present at the Benzinga Cannabis Capital Conference from August 16 to 17 in Toronto.

Simpson said, “Attending industry conferences and events provides extremely valuable insight into the health of the industry as a whole and the strategies, products and innovations that will shape the months and years to come. They are important opportunities to interact with potential investors, media, and industry leaders and to discuss the most critical topics impacting cannabis today.”




GSRX Industries Inc., through its wholly-owned subsidiary, Project 1493 LLC, announced today that it has received pre-qualification and preliminary approval for a medicinal cannabis transportation license in Puerto Rico.  This is in addition to the eight dispensary pre-qualifications it has received to date, as well as pre-qualification for a medicinal cannabis manufacturing license recently received.  Of its pre-qualified dispensary locations, Green Spirit RX dispensaries are currently operating in Dorado, Carolina, and San Juan (Hato Rey), with five locations in various stages of development and construction in Fajardo, Isla Verde, San Juan (Andalucia), Bayamón, and Old San Juan.
The pre-qualified transportation license allows GSRX to transport and deliver cannabis between authorized dispensaries and patients’ homes in Puerto Rico.  Start of medicinal cannabis delivery by GSRX in Puerto Rico is dependent upon numerous factors and will begin only after the pre-qualified business undergoes requisite inspections and is issued all requisite permits and licensing from the Puerto Rico Department of Health.

ABcann Global Corporation announced that, effective immediately, it will be known as VIVO Cannabis Inc. — a contemporary reflection of the Company’s evolution, purpose and direction. The name change became effective at market open today and “VIVO” will replace “ABCN” as the Company’s ticker symbol on the TSX Venture Exchange.
VIVO — which translates to “living” in Latin — embodies the Company’s commitment to providing quality cannabis products and services that improve lives. It’s the common thread that unites us all, and it’s the spirit behind the rebranding. It also celebrates the recent announcement of the Company’s proposed acquisition of Canna Farms Limited.

ALGAE DYNAMICS CORP , a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, today announced it has received funding of CDN$520,000 through the sale of $100,000 Canadian 10% Convertible Debentures (convertible into 400,000 shares of common stock at $0.25 CAN) and $420,000 CAN through the sale of 1,050,000 shares of restricted Common stock at $0.40 CAN and the issuance of 525,000 purchase warrants at $0.75 CAN via an Offering Memorandum from accredited investors.
The Company intends to use the funds to further support Dr. Steven Laviolette and his team at Western University and Dr. Jonathan Blay at The University of Waterloo (announced previously).
Funds will also be allocated for patent applications, supporting development activities with their Licensed Partners, general administrative expenses and compliance.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


This podcast is sponsored by Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com



Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com
800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing